EDGAR Filing Documents for 0001279569-07-001294

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001279569-07-001294

Filing Date

2007-08-30

Accepted

2007-08-30 11:24:57

Documents

Period of Report

2007-05-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 6-K	lorus6k.htm	6-K	17327
2	ANNUAL FINANCIAL STATEMENTS	ex991.htm	EX-99.1	1147787
3	MANAGEMENT DISCUSSION AND ANALYSIS	ex992.htm	EX-99.2	324241
4	ANNUAL INFORMATION FORM	ex993.htm	EX-99.3	589417
5	CEO/CFO CERTIFICATIONS	ex994.htm	EX-99.4	28843
6	GRAPHIC	chart.jpg	GRAPHIC	26701
7	GRAPHIC	lorusgraphic.jpg	GRAPHIC	8890
	Complete submission text file	0001279569-07-001294.txt		2158569

Mailing Address 2 MERIDIAN ROAD TORONTO A6 M9W 4Z7

Business Address 2 MERIDIAN ROAD . TORONTO A6 M9W 4Z7

LORUS THERAPEUTICS INC (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0531
Type: 6-K | Act: 34 | File No.: 001-32001 | Film No.: 071089955
SIC: 2836 Biological Products, (No Diagnostic Substances)